Donor | Recipient | Treatment | Group purpose | Assessments (d) |
---|---|---|---|---|
C57BL/6 | C57BL/6 | Saline | Saline-treated syngeneic control | 8–14, 20, 28, 90 |
BALB/c | C57BL/6 | Saline | Saline-treated allogeneic control | 8–14, 20, 28, 90 |
BALB/c | C57BL/6 | iPSC-derived MSCs | To test the efficacy of iPSC-derived MSCs | 8–14, 20, 28, 90 |